Epic Medical Research has officially become part of hyperCORE International's global partner site network, a move that significantly enhances the scope and efficiency of clinical trials worldwide. Based in Dallas, Texas, Epic Medical Research operates across 12 state-of-the-art locations, specializing in a broad spectrum of therapeutic areas including metabolic disorders, fatty liver disease, and neurological conditions, among others.
Dr. Haresh Boghara, President & Principal Investigator at Epic, expressed enthusiasm about the partnership, highlighting the shared commitment to advancing clinical research and improving patient outcomes. The collaboration with hyperCORE International is expected to provide Epic with access to greater resources and a broader platform for delivering innovative clinical trial solutions.
Nicholas Focil, President of hyperCORE International, commended Epic Medical Research for its therapeutic breadth and operational scale, noting the alignment with hyperCORE's mission to enhance trial performance across its network. This partnership is poised to streamline operations and accelerate results in clinical research, benefiting from the combined expertise and resources of both organizations.
hyperCORE International, founded in 2019, is a network of leading clinical research site organizations with over 80 active trial sites across five countries. The network's collaborative approach, focusing on efficiency, standardization, and excellence, has facilitated the completion of more than 7,000 studies involving over 140,000 participants. The addition of Epic Medical Research to this network underscores hyperCORE's commitment to advancing clinical research through strategic partnerships.
For more information on hyperCORE International and its initiatives, visit https://www.hypercoreinternational.com.
